SG11201906215VA - X-ray markers for scaffolds - Google Patents
X-ray markers for scaffoldsInfo
- Publication number
- SG11201906215VA SG11201906215VA SG11201906215VA SG11201906215VA SG11201906215VA SG 11201906215V A SG11201906215V A SG 11201906215VA SG 11201906215V A SG11201906215V A SG 11201906215VA SG 11201906215V A SG11201906215V A SG 11201906215VA SG 11201906215V A SG11201906215V A SG 11201906215VA
- Authority
- SG
- Singapore
- Prior art keywords
- international
- rule
- applicant
- pct
- ray markers
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/82—Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B90/00—Instruments, implements or accessories specially adapted for surgery or diagnosis and not covered by any of the groups A61B1/00 - A61B50/00, e.g. for luxation treatment or for protecting wound edges
- A61B90/39—Markers, e.g. radio-opaque or breast lesions markers
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B23—MACHINE TOOLS; METAL-WORKING NOT OTHERWISE PROVIDED FOR
- B23P—METAL-WORKING NOT OTHERWISE PROVIDED FOR; COMBINED OPERATIONS; UNIVERSAL MACHINE TOOLS
- B23P15/00—Making specific metal objects by operations not covered by a single other subclass or a group in this subclass
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B90/00—Instruments, implements or accessories specially adapted for surgery or diagnosis and not covered by any of the groups A61B1/00 - A61B50/00, e.g. for luxation treatment or for protecting wound edges
- A61B90/39—Markers, e.g. radio-opaque or breast lesions markers
- A61B2090/3966—Radiopaque markers visible in an X-ray image
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2250/00—Special features of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
- A61F2250/0058—Additional features; Implant or prostheses properties not otherwise provided for
- A61F2250/0071—Additional features; Implant or prostheses properties not otherwise provided for breakable or frangible
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2250/00—Special features of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
- A61F2250/0058—Additional features; Implant or prostheses properties not otherwise provided for
- A61F2250/0096—Markers and sensors for detecting a position or changes of a position of an implant, e.g. RF sensors, ultrasound markers
- A61F2250/0098—Markers and sensors for detecting a position or changes of a position of an implant, e.g. RF sensors, ultrasound markers radio-opaque, e.g. radio-opaque markers
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Oral & Maxillofacial Surgery (AREA)
- Public Health (AREA)
- Heart & Thoracic Surgery (AREA)
- Surgery (AREA)
- Cardiology (AREA)
- Transplantation (AREA)
- Vascular Medicine (AREA)
- Pathology (AREA)
- Molecular Biology (AREA)
- Medical Informatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Mechanical Engineering (AREA)
- Media Introduction/Drainage Providing Device (AREA)
- Materials For Medical Uses (AREA)
- Prostheses (AREA)
- Analysing Materials By The Use Of Radiation (AREA)
Abstract
INTERNATIONAL APPLICATION PUBLISHED UNDER THE PATENT COOPERATION TREATY (PCT) (19) World Intellectual Property Organization International Bureau (43) International Publication Date 19 July 2018 (19.07.2018) WIPO I PCT omit VIII °nolo mmono iflo oimIE (10) International Publication Number WO 2018/130489 Al (51) International Patent Classification: A61F 2/82 (2013.01) A61F 2/04 (2013.01) (21) International Application Number: PCT/EP2018/050345 (22) International Filing Date: 08 January 2018 (08.01.2018) (25) Filing Language: English (26) Publication Language: English (30) Priority Data: 17150973.0 11 January 2017 (11.01.2017) EP (71) Applicant: BIOTRONIK AG [CH/CH]; Ackerstrasse 6, 8180 Billach (CH). (72) Inventors: BAYER, Ullrich; Am Brink 11, 18209 Bad Doberan (DE). RISCH, Fabian; Vorstadt 13, 8200 Schaffhausen (CH). RIEDMULLER, Johannes; Dahlmannstrasse 98, 90491 Niirnberg (DE). QUINT, Bo- do; Hauptstrasse 38, 79802 Dettighofen (DE). (74) Agent: RANDOLL, Soren; BIOTRONIK SE & Co. KG, Woermannkehre 1, 12359 Berlin (DE). (81) Designated States (unless otherwise indicated, for every kind of national protection available): AE, AG, AL, AM, AO, AT, AU, AZ, BA, BB, BG, BH, BN, BR, BW, BY, BZ, CA, CH, CL, CN, CO, CR, CU, CZ, DE, DJ, DK, DM, DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, IL, IN, IR, IS, JO, JP, KE, KG, KH, KN, KP, KR, KW, KZ, LA, LC, LK, LR, LS, LU, LY, MA, MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PA, PE, PG, PH, PL, PT, QA, RO, RS, RU, RW, SA, SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TH, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW. (84) Designated States (unless otherwise indicated, for every kind of regional protection available): ARIPO (BW, GH, GM, KE, LR, LS, MW, MZ, NA, RW, SD, SL, ST, SZ, TZ, UG, ZM, ZW), Eurasian (AM, AZ, BY, KG, KZ, RU, TJ, TM), European (AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR), OAPI (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, KM, ML, MR, NE, SN, TD, TG). (54) Title: X-RAY MARKERS FOR SCAFFOLDS 22 200 FIG. 8 1-1 (57) : The invention relates to a method for producing x-ray markers (1), during which method a predetermined breaking point (21) is severed in order to detach x-ray markers (1) from part (22) of a material layer (2). The invention also relates to an x-ray marker, C a medical implant, and a semifinished product. [Continued on next page] WO 2018/130489 Al MIDEDIMOMOIDEIREIE3011100VIVEHMOVOIMIE Declarations under Rule 4.17: as to the identity of the inventor (Rule 4.17(i)) as to applicant's entitlement to apply for and be granted a patent (Rule 4.17(ii)) as to the applicant's entitlement to claim the priority of the earlier application (Rule 4.17(iii)) Published: — with international search report (Art. 21(3))
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP17150973.0A EP3348239A1 (en) | 2017-01-11 | 2017-01-11 | X-ray markers for scaffolds |
| PCT/EP2018/050345 WO2018130489A1 (en) | 2017-01-11 | 2018-01-08 | X-ray markers for scaffolds |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SG11201906215VA true SG11201906215VA (en) | 2019-08-27 |
Family
ID=57906414
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG11201906215VA SG11201906215VA (en) | 2017-01-11 | 2018-01-08 | X-ray markers for scaffolds |
Country Status (8)
| Country | Link |
|---|---|
| US (2) | US11951024B2 (en) |
| EP (2) | EP3348239A1 (en) |
| JP (1) | JP7093356B2 (en) |
| CN (1) | CN110121316B (en) |
| AU (1) | AU2018207805B2 (en) |
| ES (1) | ES2874334T3 (en) |
| SG (1) | SG11201906215VA (en) |
| WO (1) | WO2018130489A1 (en) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP3560452B1 (en) | 2018-04-24 | 2024-05-15 | Biotronik Ag | Marker element and method for its production |
| DE102018113810A1 (en) * | 2018-06-11 | 2019-12-12 | Cortronik GmbH | Function marker element and method for its production |
| US11266481B2 (en) * | 2018-10-12 | 2022-03-08 | Hologic, Inc. | Tissue localization marker with D-shaped cross-section |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5824042A (en) * | 1996-04-05 | 1998-10-20 | Medtronic, Inc. | Endoluminal prostheses having position indicating markers |
| GB0020491D0 (en) * | 2000-08-18 | 2000-10-11 | Angiomed Ag | Stent with attached element and method of making such a stent |
| US8464927B2 (en) * | 2003-10-17 | 2013-06-18 | Jmp Laboratories, Inc. | Processing apparatus fabrication |
| WO2005083406A1 (en) * | 2004-02-20 | 2005-09-09 | Philips Intellectual Property & Standards Gmbh | Device and method for mapping the distribution of an x-ray fluorescence marker |
| US7967807B2 (en) | 2007-03-16 | 2011-06-28 | Medtronic Vascular, Inc. | Vascular fluoroscopic marker |
| GB0717481D0 (en) * | 2007-09-07 | 2007-10-17 | Angiomed Ag | Self-expansible stent with radiopaque markers |
| DE102008043970A1 (en) * | 2008-11-21 | 2010-05-27 | Biotronik Vi Patent Ag | A method for producing a corrosion-inhibiting coating on an implant of a biocorrodible magnesium alloy and implant produced by the method |
| EP2399619B1 (en) | 2010-06-25 | 2015-08-05 | Biotronik AG | Implant and Method for Manufacturing Same |
| EP2457601B1 (en) | 2010-11-08 | 2015-07-22 | Biotronik AG | Marker composite and medical implant comprising an x-ray marker |
| US8992761B2 (en) * | 2012-07-13 | 2015-03-31 | Abbott Cardiovascular Systems, Inc. | Methods for passivating metallic implantable medical devices including radiopaque markers |
| EP3068345B1 (en) * | 2013-11-15 | 2020-08-26 | Guy's And St. Thomas' NHS Foundation Trust | Information markers for heart prostheses |
| DE102013020689B3 (en) | 2013-12-04 | 2015-02-19 | Admedes Schuessler Gmbh | A body implant and method of making the same and method of improving radiopacity |
| CN204207881U (en) * | 2014-07-17 | 2015-03-18 | 微创神通医疗科技（上海）有限公司 | A kind of intravascular stent |
-
2017
- 2017-01-11 EP EP17150973.0A patent/EP3348239A1/en not_active Withdrawn
-
2018
- 2018-01-08 CN CN201880005598.XA patent/CN110121316B/en active Active
- 2018-01-08 WO PCT/EP2018/050345 patent/WO2018130489A1/en unknown
- 2018-01-08 ES ES18700640T patent/ES2874334T3/en active Active
- 2018-01-08 JP JP2019536136A patent/JP7093356B2/en active Active
- 2018-01-08 AU AU2018207805A patent/AU2018207805B2/en active Active
- 2018-01-08 SG SG11201906215VA patent/SG11201906215VA/en unknown
- 2018-01-08 US US16/475,544 patent/US11951024B2/en active Active
- 2018-01-08 EP EP18700640.8A patent/EP3568111B1/en active Active
-
2024
- 2024-03-08 US US18/599,350 patent/US20240207076A1/en active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| EP3348239A1 (en) | 2018-07-18 |
| US11951024B2 (en) | 2024-04-09 |
| AU2018207805A1 (en) | 2019-07-18 |
| JP7093356B2 (en) | 2022-06-29 |
| US20190336310A1 (en) | 2019-11-07 |
| EP3568111B1 (en) | 2021-03-03 |
| US20240207076A1 (en) | 2024-06-27 |
| EP3568111A1 (en) | 2019-11-20 |
| WO2018130489A1 (en) | 2018-07-19 |
| AU2018207805B2 (en) | 2023-12-14 |
| JP2020503935A (en) | 2020-02-06 |
| CN110121316B (en) | 2022-02-18 |
| CN110121316A (en) | 2019-08-13 |
| ES2874334T3 (en) | 2021-11-04 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| SG11201807912SA (en) | Vaccine against rsv | |
| SG11201808622SA (en) | Chimeric receptors to flt3 and methods of use thereof | |
| SG11201908971RA (en) | Erbb-2 and erbb3 binding bispecific antibodies for use in the treatment f cells that have an nrg1 fusion gene | |
| SG11201803697SA (en) | Method for the economic manufacturing of metallic parts | |
| SG11201909432SA (en) | Compounds for increasing genome editing efficiency | |
| SG11201811431VA (en) | Multispecific antibodies against cd40 and cd137 | |
| SG11201907402SA (en) | Population-based immunogenic peptide identification platform | |
| SG11201909011PA (en) | Niraparib compositions | |
| SG11201807913XA (en) | Stabilized soluble pre-fusion rsv f proteins | |
| SG11201408092UA (en) | Endoprosthesis and delivery device for implanting such endoprosthesis | |
| SG11201809908TA (en) | Stabilized glycopeptide antibiotic formulations | |
| SG11201808713YA (en) | Ophthalmic compositions comprising levodopa, an antioxidant and an aqueous carrier | |
| SG11201901351UA (en) | A patient interface, system and method | |
| SG11201404836QA (en) | Long-acting coagulation factors and methods of producing same | |
| SG11201810078PA (en) | Stabilized pre-fusion rsv f proteins | |
| SG11201909024XA (en) | Obtaining data from targets using imagery and other remote sensing data | |
| SG11201900618WA (en) | Permanently polarized hydroxyapatite, a process for its manufacture and uses thereof | |
| SG11201809875VA (en) | Compositions and methods for treating spinal muscular atrophy | |
| SG11201809882XA (en) | Pharmaceutical combinations for treating cancer | |
| SG11201806393QA (en) | Use of gabaa receptor modulators for treatment of itch | |
| SG11201906215VA (en) | X-ray markers for scaffolds | |
| SG11201906383WA (en) | A layered medical data computer architecture | |
| SG11201908513RA (en) | Peptides for treatment of diabetes | |
| SG11201907199QA (en) | Cancer treatment | |
| SG11201806716UA (en) | Virtualized network function interworking |